InvestorsHub Logo

mcbio

08/10/11 1:58 AM

#124936 RE: jq1234 #124894

Linaclotide potentially could be a big drug.

You think that's already priced into the stock's $1B+ market cap though? Also, looks like this is their only drug so you probably need to have the utmost of confidence the drug will sail through the FDA and be a blockbuster on the market to be invested here.

genisi

08/10/11 4:50 AM

#124941 RE: jq1234 #124894

In these trials, statistically significant improvements in abdominal and bowel symptoms were achieved for linaclotide-treated patients versus placebo-treated patients for all primary and secondary endpoints.

I think efficacy against abdominal pain is the big issue that was not specifically named in the part you've posted.